163 related articles for article (PubMed ID: 1967317)
21. Several down, a few to go: histamine H3 receptor ligands making the final push towards the market?
Kuhne S; Wijtmans M; Lim HD; Leurs R; de Esch IJ
Expert Opin Investig Drugs; 2011 Dec; 20(12):1629-48. PubMed ID: 21992603
[TBL] [Abstract][Full Text] [Related]
22. [The histamine H(3) receptor: a target for new drugs].
Arrang JM
Ann Pharm Fr; 2003 May; 61(3):173-84. PubMed ID: 12714930
[TBL] [Abstract][Full Text] [Related]
23. Histamine H3 receptor as a drug discovery target.
Berlin M; Boyce CW; Ruiz Mde L
J Med Chem; 2011 Jan; 54(1):26-53. PubMed ID: 21062081
[No Abstract] [Full Text] [Related]
24. The basics of histamine biology.
Lieberman P
Ann Allergy Asthma Immunol; 2011 Feb; 106(2 Suppl):S2-5. PubMed ID: 21277530
[TBL] [Abstract][Full Text] [Related]
25. Histamine, histamine receptors and antihistamines: new concepts.
Criado PR; Criado RF; Maruta CW; Machado Filho Cd
An Bras Dermatol; 2010; 85(2):195-210. PubMed ID: 20520935
[TBL] [Abstract][Full Text] [Related]
26. Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases.
Sadek B; Saad A; Sadeq A; Jalal F; Stark H
Behav Brain Res; 2016 Oct; 312():415-30. PubMed ID: 27363923
[TBL] [Abstract][Full Text] [Related]
27. Histamine and histamine receptor antagonists in cancer biology.
Blaya B; Nicolau-Galmés F; Jangi SM; Ortega-Martínez I; Alonso-Tejerina E; Burgos-Bretones J; Pérez-Yarza G; Asumendi A; Boyano MD
Inflamm Allergy Drug Targets; 2010 Jul; 9(3):146-57. PubMed ID: 20632959
[TBL] [Abstract][Full Text] [Related]
28. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
[TBL] [Abstract][Full Text] [Related]
29. Role of capsaicin-sensitive nerves and histamine H1, H2, and H3 receptors in the gastroprotective effect of histamine against stress ulcers in rats.
Dembiński A; Warzecha Z; Ceranowicz P; Brzozowski T; Dembiński M; Konturek SJ; Pawlik WW
Eur J Pharmacol; 2005 Jan; 508(1-3):211-21. PubMed ID: 15680274
[TBL] [Abstract][Full Text] [Related]
30. The influence of histamine H1-, H2- and H3-receptor antagonists on histamine stimulated NGF release from cultured astrocytes.
Lipnik-Stangelj M; Carman-Krzan M
Inflamm Res; 2001 Apr; 50 Suppl 2():S84-5. PubMed ID: 11411616
[No Abstract] [Full Text] [Related]
31. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
Esbenshade TA; Fox GB; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan L; Wetter J; Marsh K; Bennani YL; Cowart MD; Sullivan JP; Hancock AA
J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078
[TBL] [Abstract][Full Text] [Related]
32. Histamine H(4) receptors regulate ACTH release in AtT-20 cells.
Meng J; Ma X; Li M; Jia M; Luo X
Eur J Pharmacol; 2008 Jun; 587(1-3):336-8. PubMed ID: 18439995
[TBL] [Abstract][Full Text] [Related]
33. Histamine H3 and H4 receptors as novel drug targets.
Tiligada E; Zampeli E; Sander K; Stark H
Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
[TBL] [Abstract][Full Text] [Related]
34. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
[TBL] [Abstract][Full Text] [Related]
35. Histamine receptors branch out.
Hill SJ
Nature; 1987 May 14-20; 327(6118):104-5. PubMed ID: 3033514
[No Abstract] [Full Text] [Related]
36. Inhibition of sympathetic hypertensive responses in the guinea-pig by prejunctional histamine H3-receptors.
Hey JA; del Prado M; Egan RW; Kreutner W; Chapman RW
Br J Pharmacol; 1992 Oct; 107(2):347-51. PubMed ID: 1330174
[TBL] [Abstract][Full Text] [Related]
37. The histamine H3-receptor: a target for developing new drugs.
Leurs R; Timmerman H
Prog Drug Res; 1992; 39():127-65. PubMed ID: 1335582
[No Abstract] [Full Text] [Related]
38. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning and characterization of a new human histamine receptor, HH4R.
Nakamura T; Itadani H; Hidaka Y; Ohta M; Tanaka K
Biochem Biophys Res Commun; 2000 Dec; 279(2):615-20. PubMed ID: 11118334
[TBL] [Abstract][Full Text] [Related]
40. Modulation of cardiovascular function by central histamine H3 receptors in conscious guinea pigs.
McLeod RL; Gertner SB; Hey JA
Eur J Pharmacol; 1991 Dec; 209(1-2):141-2. PubMed ID: 1667638
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
